Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_assertion type Assertion NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_head.
- NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_assertion description "[In a cross-sectional study we investigated relationships between the clinical outcome and Aza dose, the TPMT genotype and the Aza metabolite levels among patients with Crohn disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_provenance.
- NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_assertion evidence source_evidence_literature NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_provenance.
- NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_assertion SIO_000772 14531535 NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_provenance.
- NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_assertion wasDerivedFrom befree-20150227 NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_provenance.
- NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_assertion wasGeneratedBy ECO_0000203 NP756535.RAw2Z5LhRVq9L_Aja9VXRC0QxEeMBlle2vOw1fMeY8w20130_provenance.